Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014


47th Course of the International School of Crystallography

30 May 2014 - 08 Jun 2014 - Erice, Italy



Bookmark and Share


Diseases, from bacterial and viral infections to cancer to chronic maladies, are still among the greatest problems for mankind, in spite of tremendous progress in genetics, biology, and chemistry.  Approaches to developing new treatments have changed over time, and so have the methodologies used, in order to solve the varied, new, challenging problems that may happen on the path to drug discovery.  Together with ever-evolving experimental techniques, a variety of computational approaches have been applied at the various stages of the drug design process, and in the past two decades structure-based drug design has become one of the mainstream approaches.  This method can be used to target protein-ligand and protein-protein interactions and nowadays is applicable to all aspects of drug discovery, including lead identification, lead optimization, ADMET prediction, and drug repurposing. 

The purpose of the course is dual:

1) It will provide a review of the fundamentals and the application of crystallography to drug design, and an evaluation of the technology at the present state.

2) It will review the progress in this field and summarize the application and results to current fields of interest.  

In addition to lectures, there will be hands-on workshops providing training in using modern computer programs.

The topics that will be covered are:

- Targeting Resistance in Design of Anti AIDS Drugs

- Molecular Modeling and Drug Design

- Targeting Protein-Protein Interactions

- Drug Design Targeting Bromodomains

- Targeting GPCRs for Drug Design

- Targeting Influenza Virus Polymerase

- The Small Molecule Universe

- Molecular Obesity and Other Addictions in Drug Discovery

- Energetics of Protein-Ligand Interactions

- Docking Experiences and Expectations

- Structure of Human G-Protein Coupled Receptor

- Using ARP/WARP for Structure-Based Drug Design

- Antibody Technologies to Stabilize Targets for NCE Screening

- Drug Design Tales from AstraZeneca

- High Resolution Protein-Ligand Interactions by X-rays and Neutrons

- Virus Structure and Antiviral Drug Design

- Structure-Based Design of Drugs Against Diabetes

- Membrane Protein Structure

- Structural Bioinformatics

- Protein Aggregation and Drug Design

- Turning on Enzymes with Small Molecules



Further information
Scientific News
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
Crystals, Super Magnets in Drug Discovery
Scientists have produced larger superparamagnetic crystals that could revolutionise drug delivery.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Snapshots of Chemical Flipping a Biological Switch
X-ray laser gets first real-time snapshots of a chemical flipping a biological switch, opening new path to understanding how RNA works.
Uncovering Elusive Proteins
Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.
Cannabinoid Receptor Structure Revealed
Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Study Unocovers Cancer-Linked Protein’s Associates
Researchers have developed a new list of nearly 100 potential partners of a cancer-linked enzyme by studying its interactions with other proteins.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!